Diacylglycerol Signaling

180 J.D. Black
Classon, M., & Dyson, N. (2001). p107 and p130: versatile proteins with interesting pockets. Exp
Cell Res, 264, 135–147.
Cobrinik, D. (2005). Pocket proteins and cell cycle control. Oncogene, 24, 2796–2809.
Coppock, D. L., Buffolino, P., Kopman, C., & Nathanson, L. (1995). Inhibition of the melanoma
cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate
(TPA) by modulation of CDK2 activity. Exp Cell Res, 221, 92–102.
Coppock, D. L., & Nathanson, L. (1993). Positive and negative growth regulation in melanoma:
growth factors, intracellular signalling, and the cell cycle. Cancer Treat Res, 65, 279–296.
Coppock, D. L., Tansey, J. B., & Nathanson, L. (1992). 12-O-tetradecanoylphorbol-13-acetate
induces transient cell cycle arrest in G1 and G2 in metastatic melanoma cells: inhibition of
phosphorylation of p34cdc2. Cell Growth Differ, 3, 485–494.
Cozzi, S. J., Parsons, P. G., Ogbourne, S. M., Pedley, J., & Boyle, G. M. (2006). Induction of
senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation
of the mitogen-activated protein kinase pathway. Cancer Res, 66, 10083–10091.
Czifra, G., Toth, I. B., Marincsak, R., Juhasz, I., Kovacs, I., Acs, P., et al. (2006). Insulin-like
growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells
and in C2C12 myoblasts. A central role of protein kinase Cdelta. Cell Signal, 18,
1461–1472.
Dangi, S., Chen, F. M., & Shapiro, P. (2006). Activation of extracellular signal-regulated kinase
(ERK) in G2 phase delays mitotic entry through p21CIP1. Cell Prolif, 39, 261–279.
Datta, N. S., Chen, C., Berry, J. E., & McCauley, L. K. (2005). PTHrP signaling targets cyclin D1
and induces osteoblastic cell growth arrest. J Bone Miner Res, 20, 1051–1064.
De Falco, G. (2006). Comes F. Simone C. pRb: master of differentiation. Coupling irreversible cell
cycle withdrawal with induction of muscle-specific transcription. Oncogene, 25, 5244–5249.
Deeds, L., Teodorescu, S., Chu, M., Yu, Q., & Chen, C. Y. (2003). A p53-independent G1 cell
cycle checkpoint induced by the suppression of protein kinase C alpha and theta isoforms. J
Biol Chem, 278, 39782–39793.
Denning, M. F. (2004). Epidermal keratinocytes: regulation of multiple cell phenotypes by multiple
protein kinase C isoforms. Int J Biochem Cell Biol, 36, 1141–1146.
Detjen, K. M., Brembeck, F. H., Welzel, M., Kaiser, A., Haller, H., Wiedenmann, B., et al. (2000).
Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)mediated
G(1) arrest. J Cell Sci, 113(Pt 17), 3025–3035.
Dicker, P., & Rozengurt, E. (1978). Stimulation of DNA synthesis by tumour promoter and pure
mitogenic factors. Nature, 276, 723–726.
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997). Inhibition of cyclin D1 phosphorylation on threonine-286
prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev, 11,
957–972.
Du, W. (2006). Pogoriler J. Retinoblastoma family genes. Oncogene, 25, 5190–5200.
Esposito, F., Cuccovillo, F., Vanoni, M., Cimino, F., Anderson, C. W., Appella, E., et al. (1997).
Redox-mediated regulation of p21(waf1/cip1) expression involves a post-transcriptional
mechanism and activation of the mitogen-activated protein kinase pathway. Eur J Biochem,
245, 730–737.
Fields, A. P., & Regala, R. P. (2007). Protein kinase C iota: human oncogene, prognostic marker
and therapeutic target. Pharmacol Res, 55, 487–497.
Fima, E., Shtutman, M., Libros, P., Missel, A., Shahaf, G., Kahana, G., et al. (2001). PKCeta
enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells.
Oncogene, 20, 6794–6804.
Fisher, R. P., & Morgan, D. O. (1994). A novel cyclin associates with MO15/CDK7 to form the
CDK-activating kinase. Cell, 78, 713–724.
Fishman, D. D., Segal, S., & Livneh, E. (1998). The role of protein kinase C in G1 and G2/M
phases of the cell cycle (review). Int J Oncol, 12, 181–186.
Frey, M. R., Clark, J. A., Bateman, N. W., Kazanietz, M. G., Black, A. R., & Black, J. D. (2004).
Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9, 13,
14-ortho-phenylacetate in intestinal epithelial cells. Biochem Pharmacol, 67, 1873–1886.